查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1666190

全球醫療旅遊市場 - 2025 年至 2033 年

Global Medical Tourism Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 156 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球醫療旅遊市場規模達到 470.9 億美元，預計到 2033 年將達到 2,303.5 億美元，2025-2033 年預測期內的複合年成長率為 19.4%。

醫療旅遊是指前往另一個國家或地區尋求醫療，通常是因為該國提供比旅行者本國更實惠、更高品質或更專業的護理。它涵蓋各種醫療保健服務，包括選擇性手術、牙科、整容手術、生育治療以及更複雜的手術或醫療干預。總體而言，醫療旅遊是一個不斷發展的行業，其動力源於人們對負擔得起的高品質醫療服務的需求，以及將治療與旅行相結合的便利性。然而，患者在進行醫療旅遊之前必須對目的地國家、醫療保健提供者和任何相關風險進行徹底的研究。

過去幾十年來，醫療旅遊市場經歷了快速成長，推動因素包括已開發國家醫療成本的上漲、醫療技術的進步、全球化以及旅遊成本的下降。例如，根據醫療旅遊協會的數據，每年約有 1400 萬人出國接受醫療，來自英國和美國等已開發國家的患者通常會前往低度開發國家獲得醫療服務，而且費用比在國內低得多。

市場動態：

促進因素與約束因素

人們對醫療程序低成本的認知不斷提高

人們對醫療程序低成本的認知不斷提高，極大地推動了醫療旅遊市場的成長，預計將在預測期內推動市場的發展。醫療旅遊的主要動機是患者可以透過到其他國家接受治療並獲得更好的治療效果來節省大量費用。這進一步為患者提供了更好、更實惠的治療。

例如，2022 年 8 月，印度衛生部啟動了一項新舉措，即“印度治愈，印度治愈”，這是總理宣布的一個新門戶網站。新入口網站旨在推動醫療旅遊的發展。該入口網站是在「印度醫療數位使命」計劃下開發的，將擁有醫療保健專業人員和醫院服務資源，以幫助海外患者以可負擔的費用在印度尋求醫療幫助。

人們對醫療程序低成本的認知不斷提高，加速了醫療旅遊市場的需求，從而增加了接受各種程序的醫療遊客的數量。例如，根據 Lively, Inc. 的數據，在印度，冠狀動脈繞道手術平均花費約為 10,000 美元，在墨西哥，冠狀動脈繞道手術平均花費約為 40,000 美元（不包括往返目的地的旅費，也不包括出院後在墨西哥的恢復費用），而在美國，該手術的平均費用為 123,000 美元。

據DentaVacation稱，匈牙利的牙醫費用比英國和其他西歐國家低 40-70%。在匈牙利，四顆牙齒植入等手術每牙弓費用為 5,200 美元，而在英國，同樣的手術費用為 15,000 美元。在匈牙利，我們只需花費 405 美元就能買到瓷貼面，而在英國，則需要花費高達 1,100 美元。

此外，根據全球醫療保健認證，墨西哥在醫療旅遊業排名第三，得分為70.05。墨西哥的醫療旅遊業正在不斷發展，擁有高品質的醫療設施和實惠的醫療費用。整形外科和癌症治療領域的領導者。韓國衛生福利部 (MOHW，部長 Cho Kyoo Hong) 宣布，2023 年有 606,000 名外國患者訪問韓國，比 2022 年的 248,000 名成長了 2.4 倍（144.2%）。

醫療旅行是一個耗時的過程，並且會產生一些額外費用

儘管醫療旅遊業發展迅速，但也面臨著一些可能阻礙其擴張的挑戰，其中主要的問題之一是醫療旅遊是一個耗時的過程，並且會產生額外的費用。這些因素可能會阻止潛在患者選擇出國治療。出國就醫不只是預訂航班那麼簡單。它通常需要一個漫長的規劃過程，包括獲得簽證、尋找醫療服務提供者、安排諮詢和確保適當的後續護理。對於時間有限或需要緊急護理的患者來說，這可能是一個重大障礙。

儘管在國外接受醫療程序本身可能更便宜，但可能會產生額外的旅遊相關費用。這些費用包括機票、住宿、交通以及目的地國家治療後護理或延長逗留的額外費用。對於部分患者來說，這可能會降低醫療旅遊的整體成本效益。例如，墨西哥整容手術的醫療旅遊套餐手術費用可能在 3,000 至 5,000 美元之間，但總費用（包括航班、住宿和術後護理）很容易達到 6,000 至 8,000 美元，因此比預期的要低。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按類型分類的程式碼片段
  • 治療片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 提高對醫療程序低成本的認知
    • 限制
      • 醫療旅行是一個耗時的過程，並且會產生一些額外費用
    • 機會
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖
  • 醫療旅遊的未來

第 5 章：醫療旅遊市場（按類型）

  • 國際醫療旅遊
  • 國內醫療旅遊

第 6 章：醫療旅遊市場（依治療方式分類）

  • 醫療
    • 牙科治療
    • 器官移植
    • 心臟手術
    • 骨科手術
    • 癌症手術
    • 生育治療
    • 整形外科
    • 其他
  • 健康和恢復活力
  • 透過傳統醫學體系治愈

第7章：醫療旅遊市場，依區域市場分析與成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 8 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第9章：公司簡介

  • Raffles Medical Group
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT 分析
  • Medobal
  • Bookimed
  • RealSelf, Inc.
  • KPJ Healthcare Berhad
  • Japan Dream Tour Co., Ltd.
  • JTB Corp.
  • SilaMed eK
  • Medibliss Tours Limited
  • American Medical Care

第 10 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 11 章：附錄

簡介目錄
Product Code: HCIT1091

The global medical tourism market reached US$ 47.09 billion in 2024 and is expected to reach US$ 230.35 billion by 2033, growing at a CAGR of 19.4% during the forecast period 2025-2033.

Medical tourism refers to traveling to another country or region to seek medical treatment, often because it offers more affordable, higher-quality or specialized care than what is available in the traveler's home country. It encompasses various healthcare services, including elective procedures, dental, cosmetic surgeries, fertility treatments and more complex surgeries or medical interventions. Overall, medical tourism is a growing industry fueled by the desire for affordable, high-quality healthcare and the convenience of combining treatment with travel. However, patients must conduct thorough research regarding destination countries, healthcare providers and any associated risks before pursuing medical tourism.

The medical tourism market has seen rapid growth over the past few decades, driven by a combination of factors including rising healthcare costs in developed countries, advancements in medical technology, globalization, and the increasing affordability of travel. For instance, around 14 million people travel abroad each year to receive medical treatment, according to the Medical Tourism Association, with patients from developed nations such as the UK and the US typically traveling to less-developed countries to access health services at a significantly lower cost than they could at home.

Market Dynamics: Drivers & Restraints

Rising awareness about the low cost of medical procedures

The rising awareness about the low cost of medical procedures is significantly driving the growth of the medical tourism market and is expected to drive the market over the forecast period. The primary motivation for medical tourism is the substantial cost savings that patients can achieve by seeking medical treatment in other countries with better patient outcomes. This further initiated more for better and more affordable treatments for the patients.

For instance, in August 2022, the Union Health Ministry launched a new initiative, heal in India and heal by India, a new portal announced by the prime minister. The new portal aims to give impetus to medical tourism. Developed under the Ayushman Bharat Digital Mission, the portal will have a repository of healthcare professionals and hospital services to help overseas patients seeking medical help in India at an affordable cost.

Rising awareness about the low cost of medical procedures accelerates the medical tourism market demand, which increases the number of medical tourists for various procedures. For instance, according to Lively, Inc., a coronary bypass averages around $10,000 in India and $40,000 in Mexico (not including travel to and from the destination, or in-country recovery after release from the hospital) and $123,000 the average procedure costs in America.

According to DentaVacation, in Hungary, dentist prices are 40-70% less than in the UK and other Western European countries. Procedures like all 4 dental implants in Hungary cost $5,200 per arch, while the same costs $15,000 in the UK. We can get porcelain veneers in Hungary at $405, whereas in the UK, they'll cost a whopping $1,100.

Additionally, according to the Global Healthcare Accreditation, Mexico ranked third in the medical tourism industry, with a score of 70.05. Mexico has a growing medical tourism industry, with high-quality medical facilities and affordable medical costs. A leader in cosmetic surgery and cancer treatment. The Ministry of Health and Welfare (MOHW, Minister Cho KyooHong) announced that 606,000 foreign patients visited Korea in 2023, achieving a 2.4 times growth (144.2%) from 248,000 in 2022. These low cost procedures awareness boosts the market demand.

Medical traveling is a time-consuming process and is associated with some additional costs

Although medical tourism has been growing rapidly, it does come with certain challenges that can hamper its expansion, one of the primary concerns being that medical traveling is a time-consuming process and can incur additional costs. These factors can deter potential patients from opting for treatment abroad. Traveling abroad for medical treatment involves more than just booking a flight. It typically requires a lengthy planning process that includes obtaining visas, researching medical providers, scheduling consultations and ensuring appropriate aftercare. This can be a significant barrier for patients with limited time or those needing urgent care.

While the medical procedure itself may be much more affordable abroad, additional travel-related costs can accumulate. These include airfares, accommodation, transport and often extra costs for post-treatment care or extended stays in the destination country. This can reduce the overall cost-effectiveness of medical tourism for some patients. For instance, a medical tourism package for cosmetic surgery in Mexico may cost between $3,000 to $5,000 for the surgery, but the total cost (including flights, accommodation, and post-operative care) can easily reach $6,000 to $8,000, making it less affordable than anticipated.

Segment Analysis

The global medical tourism market is segmented based on type, treatment and region.

Treatment:

The medical treatment segment is expected to dominate the medical tourism market share

The medical treatment segment is the dominant segment in the medical tourism market, contributing significantly to its growth. This segment includes a wide range of medical services such as surgeries, dental procedures, fertility treatments and cosmetic surgery, all of which are key drivers of medical tourism.

For instance, according to the Global Healthcare Accreditation, the data (pre-pandemic levels), the below countries have statistics and data available for medical tourism. Some countries showcase inbound and other outbound data with the average number of patients and primary types of medical procedures sought as follows:

Surgical treatments, both elective and non-elective, make up a substantial part of the medical tourism market. High-demand surgeries like orthopedic surgeries, cardiac surgeries, cosmetic surgeries and spinal surgeries drive many patients to seek affordable and high-quality care abroad. Cosmetic surgery is one of the fastest-growing sectors within medical tourism. Procedures such as breast augmentation, liposuction, facelifts, bariatric surgery and dental implants draw a large number of international patients seeking quality and affordability abroad.

Geographical Analysis

Asia-Pacific is expected to hold a significant position in the medical tourism market share

The Asia-Pacific region is undeniably the dominant region in the medical tourism market, attracting millions of international patients each year due to its high-quality healthcare services, cost-effectiveness and well-established medical infrastructure. The dominance of the APAC region in medical tourism is driven by several factors, including the affordability of treatments, the availability of world-class healthcare facilities and the expertise of medical professionals.

For instance, India is experiencing a surge in medical tourism, with a significant increase in medical tourists from Myanmar, Bangladesh and Nepal. Despite being impacted by the coronavirus pandemic, India is becoming a popular destination for 'medical value travel', and its potential in this sector is expected to grow further. In 2024, India is expected to cater to around 7.3 million medical tourists, up from an estimated 6.1 million in 2023, according to credit rating agency Crisil.

Additionally, Thailand has become a world-renowned leader in medical tourism, attracting visitors worldwide with strong support from Thailand's Medical Tourism Association and the Thai government. According to the MedPark Hospital, in 2023, Thailand's medical tourism industry is expected to be worth $6 billion, with an estimated 3 million medical tourists receiving exceptional medical treatment and rehabilitation programs for a variety of medical fields.

The APAC region is home to many internationally accredited hospitals and healthcare facilities that provide high standards of medical care. Countries like Singapore, India, Thailand and South Korea have developed reputations for excellent healthcare infrastructure, attracting patients from across the globe. For instance, India is home to top-tier hospitals like Apollo Hospitals, Fortis Healthcare and Max Healthcare, which provide high-quality care for a wide range of medical procedures. Many of these hospitals have been accredited by global standards such as JCI, ensuring international patients receive the best care.

Competitive Landscape

The major global players in the medical tourism market include Raffles Medical Group, Medobal, Bookimed, RealSelf, Inc., KPJ Healthcare Berhad, Japan Dream Tour Co., Ltd., JTB Corp., SilaMed e.K., Medibliss Tours Limited, American Medical Care and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical tourism market report delivers a detailed analysis with 54 key tables, more than 41 visually impactful figures and 156 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Treatment
  • 2.5. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Awareness About the Low Cost of Medical Procedures
    • 3.1.2. Restraints
      • 3.1.2.1. Medical Traveling is a Time-Consuming Process and is Associated with Some Additional Costs
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Regulatory and Reimbursement Landscape
    • 4.4.1. North America
    • 4.4.2. Europe
    • 4.4.3. Asia Pacific
    • 4.4.4. Latin America
    • 4.4.5. Middle East & Africa
  • 4.5. Porter's Five Force Analysis
  • 4.6. Supply Chain Analysis
  • 4.7. Patent Analysis
  • 4.8. SWOT Analysis
  • 4.9. Unmet Needs and Gaps
  • 4.10. Recommended Strategies for Market Entry and Expansion
  • 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.12. Pricing Analysis and Price Dynamics
  • 4.13. Key Opinion Leaders
  • 4.14. Future of Medical Tourism

5. Medical Tourism Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. International Medical Tourism*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Domestic Medical Tourism

6. Medical Tourism Market, By Treatment

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 6.1.2. Market Attractiveness Index, By Treatment
  • 6.2. Medical Treatment*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Dental Treatment
    • 6.2.4. Organ Transplantation
    • 6.2.5. Cardiac Surgery
    • 6.2.6. Orthopedic Surgery
    • 6.2.7. Cancer Surgery
    • 6.2.8. Fertility Treatment
    • 6.2.9. Cosmetic Surgery
    • 6.2.10. Others
  • 6.3. Wellness and Rejuvenation
  • 6.4. Cures Through Traditional Systems of Medicines

7. Medical Tourism Market, By Regional Market Analysis and Growth Opportunities

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 7.1.2. Market Attractiveness Index, By Region
  • 7.2. North America
    • 7.2.1. Introduction
    • 7.2.2. Key Region-Specific Dynamics
    • 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.2.5.1. U.S.
      • 7.2.5.2. Canada
      • 7.2.5.3. Mexico
  • 7.3. Europe
    • 7.3.1. Introduction
    • 7.3.2. Key Region-Specific Dynamics
    • 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.3.5.1. Germany
      • 7.3.5.2. U.K.
      • 7.3.5.3. France
      • 7.3.5.4. Spain
      • 7.3.5.5. Italy
      • 7.3.5.6. Rest of Europe
  • 7.4. South America
    • 7.4.1. Introduction
    • 7.4.2. Key Region-Specific Dynamics
    • 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.4.5.1. Brazil
      • 7.4.5.2. Argentina
      • 7.4.5.3. Rest of South America
  • 7.5. Asia-Pacific
    • 7.5.1. Introduction
    • 7.5.2. Key Region-Specific Dynamics
    • 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
    • 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.5.5.1. China
      • 7.5.5.2. India
      • 7.5.5.3. Japan
      • 7.5.5.4. South Korea
      • 7.5.5.5. Rest of Asia-Pacific
  • 7.6. Middle East and Africa
    • 7.6.1. Introduction
    • 7.6.2. Key Region-Specific Dynamics
    • 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment

8. Competitive Landscape and Market Positioning

  • 8.1. Competitive Overview and Key Market Players
  • 8.2. Market Share Analysis and Positioning Matrix
  • 8.3. Strategic Partnerships, Mergers & Acquisitions
  • 8.4. Key Developments in Product Portfolios and Innovations
  • 8.5. Company Benchmarking

9. Company Profiles

  • 9.1. Raffles Medical Group*
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio and Description
    • 9.1.3. Financial Overview
    • 9.1.4. Key Developments
    • 9.1.5. SWOT Analysis
  • 9.2. Medobal
  • 9.3. Bookimed
  • 9.4. RealSelf, Inc.
  • 9.5. KPJ Healthcare Berhad
  • 9.6. Japan Dream Tour Co., Ltd.
  • 9.7. JTB Corp.
  • 9.8. SilaMed e.K.
  • 9.9. Medibliss Tours Limited
  • 9.10. American Medical Care

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

  • 10.1. Data Collection Methods
  • 10.2. Data Triangulation
  • 10.3. Forecasting Techniques
  • 10.4. Data Verification and Validation

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us